Merry Christmas and Happy New Year!

28 December 2024

We are NovaMedica — a Russian pharmaceutical company that develops, manufactures, and promotes innovative medications addressing the unique needs of patients with CNS disorders.

We value and take pride in the achievements of 2024!

I extend my gratitude to every employee of the NovaMedica group of companies for their hard work, intelligence, and time dedicated to the development of the company, care for patients, and contributions to expanding medical knowledge on the diagnosis and treatment of chronic CNS disorders.

Trust and teamwork enable us to improve and multiply our successes! The invaluable experience of working together — small victories, challenges, new insights, and the search for unconventional solutions — has become the most precious capital that we reinvest in the future. For the sake of six and two new patients diagnosed with CDKL5, we accomplished the impossible — ensuring a record-breaking supply of an unregistered medication in Russia.

The values of our company have been tested repeatedly, and we are convinced that WE succeed together when we prioritize the interests of patients, implement innovative solutions, and take full responsibility for everything we do!

With enthusiasm and optimism, we plan for a new 2025!

Wishing you happiness and good health!

General Director of NovaMedica

Elena LITVINOVA

Print

Our news

All news

Media Center

Read more